\"
27-29 June, 2016
The Marker San Francisco, San Francisco, CA

Media Center

Download 2016 Agenda

Challenges and regulations for storing, handling, and distributing biologics are forever changing, which is why the BioLogistics Summit has returned for the fourth year to provide you with leading edge information.

We have assembled your most notable peers from forward-thinking biopharmaceutical companies, biobanks, wholesalers, CRO’s, and CMO’s to discuss the newest challenges and regulations that will impact your business in the coming months.

Download the 3-day agenda to see a list of early confirmed speakers, the topics they will highlight, details on interactive sessions and networking opportunities!  

If you would prefer to receive this by email contact us at enquiryIQPC@iqpc.com

Fast Track Your Attendance

Cold Chain Pharma Healthcare Calendar of Events

View a list of Cold Chain Pharma Healthcare's upcoming events.

If you prefer, email enquiryiqpc@iqpc.com or call 1-800-882-8684

Past Attendee Snapshot

CEOs, Directors of Life Science Logistics, and Product Logistics Managers representing top brands from the industry are already signing up to join us at the summit. This document details the previous summit's attendees, many of whom will likely be present again this year. Will you be there to meet and network with them?

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

BioLogistics Registration Form

To register for the BioLogistics 2016 Summit, complete the form. For more information on the conference please contact enquiryIQPC@iqpc.com or 1-800-882-8684.

Convince Your Boss Letter

Present your boss with this customizable letter detailing the reasons why you should attend the upcoming BioLogistics Summit this June in San Francisco and you'll be sure to receive permission to join us.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Current Attendee Snapshot

We are expecting a large and experienced turnout at the BioLogistics Summit. Find out which of your peers will join us on the show floor in San Francisco this June.

Exclusive Content

Five Key Supply Chain Solutions

With the global healthcare cold chain market poised to reach $13.4 billion by 2020, the pressure is on to identify and resolve issues in the supply path. We have compiled some of the toughest challenges you face and paired them with related speaker sessions to give you a taste of the dialogue which will unfold at the event.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

This Just In BioLogistics News 2016

Vaccine controversy in China. The lithium ion battery ban on airlines. And an old player entering the stage. A lot is happening in the Biologic shipping space as 2016 unfolds. We’ve taken the liberty of rounding up the most relevant news stories of the past few months. Keep your finger on the pulse in advance of the 4th BioLogistics Summit this June.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

eBook - Applying GDP to Biologics

Past speaker Mary Foster, PharmD - USP Chair - PSD Expert Committee 2015-2020, presented a workshop on the applications of Good Distribution Practices to biologic shipping at the last summit. We have transcribed the session, including attendee dialogue, into this 50-page eBook. Do GDP guidelines apply to your business?

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

USP Packaging, Storage & Distribution Proposed General Chapter <1083> GDP Mid-Year 2015 Update

Past speaker Mary Foster, PharmD - USP Chair - PSD Expert Committee 2015-2020, discusses the applications of Good Distribution Practices to biologic shipping, the stance of the FDA, EMA, and other agencies, and the proposed Chapter <1083> in this past presentation.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

PDF

2016 BioLogistics Summit Press Release

Take a look at the Press Release with quotes from our production team. 

If you prefer, email 
Jazmine.Jones@iqpc.com or call 1-800-882-8684

Sponsorship Information

4th Annual BioLogistics Summit - Sponsorship Prospectus

Please complete the form below to download the sponsorship prospectus. Alternatively, feel free to send your request to Terence.Wu@iqpc.com

Video

Roche's Lisa Mazzoni on Operational Excellence in Cold Chain

Lisa Mazzoni, Operational Excellence Specialist, Global Packaging Development, Roche, talks to Cold Chain IQ about the important trends in green logistics and regulations for control room temperature shipments. 

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Whitepapers

Stability Budget: Data the Superhero

If the product is temperature controlled, how do you know it’s been kept in correct temperature and quality conditions from source of APIs, to manufacture, through multiple legs of distribution to patient? How do you track excursions along multiple legs of an end-to-end regulated complex supply chain? Can stability data really save the life of your products, and prevent millions of dollar loss to your company? We answer all these questions and more in this whitepaper, courtesy of Elpro.

Warehouse Mapping of GxP Storage Facilities: Why it’s Not an Option

When your warehouse stores temperature sensitive pharmaceuticals and life science products, a top of the line HVAC system with carefully placed thermostats is not enough to ensure product quality and consumer safety. Why? It is the nature of warehouse facilities, no matter the size, to experience temperature gradients. Organizations for regulatory guidelines and industry standards, such as the FDA, ICH and USP, have recognized that the storage and distribution of these critical products require businesses to take a risk-based approach to their operations. How is this accomplished? Temperature mapping. And it’s not an option; it’s mandatory for compliance, and this article covers the basics of what you need to know.

Courtesy of Elpro

Whitepaper: Clinical Trial Outsourcing

The number of clinical trials being outsourced is increasing and the industry is working together to develop ground-breaking partnerships that focus on creative contracting and effective oversight.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Exclusive Content

A “last mile” shipping system for the global clinical network

Past speaker Justin Bourret, Engineer II at Genetech, discusses implementing a shipping system to maintain product quality, working with suppliers, evaluating risks, and more in this past presentation.


If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Case Study: Using Your Temperature Data to Ensure Sufficient Control in Your Specialty Bio/Pharma Supply Chain

Past speakers Amy Dailey, Manager, Global Clinical Ops, Labeling & Systems at Allergan, and Tim Anderson, Account Manager, West at ELPRO, delve into why temperature data is important beyond product release, Allergan’s approach to monitoring, training clinical site staff and correcting handling errors, and more!

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Case Study: -35 ͦ Pallet Shipper

Past speaker Laura Yee, Project Manager at Bayer Technology Services, covers thermal pallet shipper requirements, initial screening processes, live shipment evaluation, and more in this past presentation.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Establishing Ambient Profiles for Robust Packaging Design

This presentation provides specific options and case studies which serve to illustrate the process of creating an ambient profile for CRT products. Lisa Mazzoni, Senior Specialist Operational Excellence at Genetech / Roche, discusses how things such as weather conditions, type of transport, and storage facilities affect the product, and how these factors ultimately inform package design.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Innovative Last Mile and Replenishment Cold Chain

Learn about the cold chain insulated tote process refined over several years of testing and customer beta projects, which has resulted in standardization and operational efficiencies of approximately $18 billion in annual delivery of refrigerated pharmaceuticals, and an 85% average reduction of product losses for Cardinal Health in the first year. Alternate cold chain applications are also covered in this presentation by Chris Anderson, Director, Quality and Regulatory Affairs of Cardinal Health.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Building a Quality Cold Chain & Temperature Management Strategy

Underlining the priorities – quality and safety – this presentation sheds light on packaging innovations, key drivers, and desired results concerning the global cold chain strategy. Jim Bacon, Senior Director – Global Demand Planning & Customer Operations at Grifols, Inc, identifies the weak links in the process, addresses the challenge of balancing flexibility and discipline, and defines a successful system.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Enhancing Profitability by Improving Partner Relationships

Customers have to rely on expert suppliers who are able to accompany them in all the steps of their cold chain logistics problems. This presentation discusses optimizing logistics costs while maintaining good customer relationships and driving innovation.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

The Global Effort to Protect Product

Alan Spears goes into great details about TAPA's (Transported Asset Protection Association) strategic intent, standards and solutions. He also goes into the elements of a good freight security program, assessment areas, and examples of good facility processes.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Articles

Ebola Exposes Global Cold Chain Weakness

In the wake of a significant slowdown of new Ebola cases, the World Health Organization declared that the virus has been suppressed too quickly for relevant data to be gathered on the disease. Is this the result of an effective and fast-acting global medical system, or does it speak to a lack of preparation and a sluggish biologic cold chain?

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Regulatory Growing Pains Heat Up Cold Chain

Biologics companies face a unique paradox. Inconsistent regulations surrounding their in-transit production one hand, and a Byzantine shipping process on the other, result in clinical delays, and ultimately potential financial losses. Streamlining the cold chain, and aligning the priorities of shippers, handlers, and legislators, are paramount, both to improve the current state of the industry and to future global healthcare.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Interviews

USP Perspective: Biologics and Clinical Trials

Mary Foster, the chair of the USP's committe on Packaging, Storage and Distribution, discusses the regulatory challenges of transporting and distributing clinical trial materials and biologics, and also her position with Athena Pharma Solutions.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Speaker Perspectives: Lisa Mazzoni

Lisa Mazzoni, Operational Excellence, Global Packaging Development, Roche, has built up years of expertise in global logistics after stops at Baxter, Genentech and now Genentech/Roche. In this interview, she discusses the challenges of biologics from a packaging perspective and establishing ambient profiles for packaging.

If you prefer to receive a copy via email contact us at enquiryIQPC@iqpc.com

Stability Above All for BioLogistics Excellence

How stable is your BioLogistics workflow? We spoke with Rebecca Gentile, Senior Specialist, Quality, Vaccine and Biological Stability at Merck, and speaker at the upcoming summit. We asked her about the challenges she faces, and what the future holds. If you prefer, email Jazmine.Jones@iqpc.com or call 1-800-882-8684

Podcasts

Transporting and Distributing Biologics

Gary Hutchinson, President of Modality Solutions, has spent over a decade directing cold chain logistics at Amgen and Edwards Lifesciences. In this podcast, he discusses best practices for transporting biologics and what technologies will impact the supply chain in the future.

DGAC Chairman Jay Johnson on Regulatory Compliance in Biologistics

In this exclusive interview Jay Johnson, DGSA, Regulatory Compliance from Inmark, and Chairman of the Dangerous Goods Advisory Council (DGAC) Board of Directors, speaks to Andrea Charles from Cold Chain IQ, about new initiatives at the DGAC, the key challenges of shipping dangerous biologics and shares his top tip for successful secure and efficient intermodal transportation of biologics. Johnson also highlights the difficulties biologic manufacturers face in navigating evolving biologic transport regulations, greater harmonisation between regulations and the most common violations.

Want Better Biologistics? Remove Your Organisational Silos

What is the weakest link in cold chain supply? Will cloud computing revolutionize the biopharmaceutical supply chain? In this interview Carlos Castro Global Transportation and Logistics, Bayer Healthcare and Andrea Charles from Cold Chain IQ, discuss the importance of quality biologistics, key regulatory and operation considerations for cold chain supply and future trends in the global pharmaceutical logistics.

Crescendo Bioscience's Meserve Platt on Reverse Logistics Management

In this interview Meserve Platt, Associate Director Materials / Facilities, Crescendo Bioscience, Inc., speaks to Andrea Charles from Cold Chain IQ, about finding the right partners to improve service levels, managing reverse logistics and 3rd party partnerships and collaborations. Platt also shares his future outlook on the diagnostic landscape. 

Regulatory Challenges of Biologics and Clinical Trials

Mary Foster is the chair of the USP's committe on Packaging, Storage and Distribution. In this podcast, she discusses the regulatory challenges of transporting and distributing clinical trial materials and biologics, and also her position with Athena Pharma Solutions.